{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:05:03Z","timestamp":1793927103327,"version":"4.8.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03248-3","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:45:50Z","timestamp":1781235950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrating inflammation, insulin resistance, and visceral adiposity: the C-reactive protein\u2013triglyceride\u2013glucose-Chinese visceral adiposity (CTI\u2013CVAI) index is associated with cardiovascular disease risk across CKM stages 0\u20133 in a nationwide prospective cohort"],"prefix":"10.1186","volume":"25","author":[{"given":"Qian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guihua","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"3248_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2025.100985","volume":"22","author":"J Li","year":"2025","unstructured":"Li J, Wei X. Association of cardiovascular\u2013kidney\u2013metabolic syndrome with all-cause and cardiovascular mortality: A prospective cohort study. Am J Prev Cardiol. 2025;22:100985.","journal-title":"Am J Prev Cardiol"},{"key":"3248_CR2","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/747861","volume":"2011","author":"M Raimundo","year":"2011","unstructured":"Raimundo M, Lopes JA. Metabolic syndrome, chronic kidney disease, and cardiovascular disease: a dynamic and life-threatening triad. Cardiol Res Pract. 2011;2011:747861.","journal-title":"Cardiol Res Pract"},{"issue":"20","key":"3248_CR3","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular\u2013kidney\u2013metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023;148(20):1606\u201335.","journal-title":"Circulation"},{"issue":"7","key":"3248_CR4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1681\/ASN.0000000637","volume":"36","author":"SE Claudel","year":"2025","unstructured":"Claudel SE, Schmidt IM, Waikar SS, et al. Cumulative incidence of mortality associated with cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome. J Am Soc Nephrol. 2025;36(7):1343\u201351.","journal-title":"J Am Soc Nephrol"},{"key":"3248_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14082833","author":"V Mutruc","year":"2025","unstructured":"Mutruc V, Bologa C, \u0218orodoc V, et al. Cardiovascular\u2013kidney\u2013metabolic syndrome: a new paradigm in clinical medicine or going back to basics? J Clin Med. 2025. https:\/\/doi.org\/10.3390\/jcm14082833.","journal-title":"J Clin Med"},{"issue":"11","key":"3248_CR6","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/jamacardio.2023.3241","volume":"8","author":"JW Ostrominski","year":"2023","unstructured":"Ostrominski JW, Arnold SV, Butler J, et al. Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999\u20132020. JAMA Cardiol. 2023;8(11):1050\u201360.","journal-title":"JAMA Cardiol"},{"issue":"20","key":"3248_CR7","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Neeland IJ, Tuttle KR, et al. A synopsis of the evidence for the science and clinical management of cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148(20):1636\u201364.","journal-title":"Circulation"},{"issue":"10","key":"3248_CR8","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1161\/01.CIR.0000140677.20606.0E","volume":"110","author":"S Malik","year":"2004","unstructured":"Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245\u201350.","journal-title":"Circulation"},{"issue":"24","key":"3248_CR9","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","volume":"148","author":"SS Khan","year":"2023","unstructured":"Khan SS, Coresh J, Pencina MJ, et al. Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular\u2013kidney\u2013metabolic health: a scientific statement from the American Heart Association. Circulation. 2023;148(24):1982\u20132004.","journal-title":"Circulation"},{"issue":"6","key":"3248_CR10","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.117.308903","volume":"121","author":"P Joseph","year":"2017","unstructured":"Joseph P, Leong D, McKee M, et al. Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circ Res. 2017;121(6):677\u201394.","journal-title":"Circ Res"},{"issue":"9709","key":"3248_CR11","first-page":"132","volume":"375","author":"S Kaptoge","year":"2009","unstructured":"Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2009;375(9709):132\u201340.","journal-title":"Lancet"},{"issue":"1","key":"3248_CR12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12933-025-02758-w","volume":"24","author":"X Gao","year":"2025","unstructured":"Gao X, Chen T, Zhou F, et al. The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2025;24(1):200.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3248_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s40001-025-02340-w","volume":"30","author":"S Xu","year":"2025","unstructured":"Xu S, Cai Y, Hu H, et al. Correlation of visceral adiposity index and dietary profile with cardiovascular disease based on decision tree modeling: a cross-sectional study of NHANES. Eur J Med Res. 2025;30(1):123.","journal-title":"Eur J Med Res"},{"issue":"1","key":"3248_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02591-1","volume":"24","author":"C Li","year":"2025","unstructured":"Li C, Zhang Z, Luo X, et al. The triglyceride-glucose index and its obesity-related derivatives as predictors of all-cause and cardiovascular mortality in hypertensive patients: insights from NHANES data with machine learning analysis. Cardiovasc Diabetol. 2025;24(1):47.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3248_CR15","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12933-025-02675-y","volume":"24","author":"D Mo","year":"2025","unstructured":"Mo D, Zhang P, Zhang M, et al. Cholesterol, high-density lipoprotein, and glucose index versus triglyceride-glucose index in predicting cardiovascular disease risk: a cohort study. Cardiovasc Diabetol. 2025;24(1):116.","journal-title":"Cardiovasc Diabetol"},{"issue":"11","key":"3248_CR16","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1113\/JP282728","volume":"601","author":"SB Vasamsetti","year":"2022","unstructured":"Vasamsetti SB, Natarajan N, Sadaf S, et al. Regulation of cardiovascular health and disease by visceral adipose tissue-derived metabolic hormones. J Physiol. 2022;601(11):2099\u2013120.","journal-title":"J Physiol"},{"key":"3248_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1284144","volume":"15","author":"Y Ren","year":"2024","unstructured":"Ren Y, Hu Q, Li Z, et al. Dose-response association between Chinese visceral adiposity index and cardiovascular disease: a national prospective cohort study. Front Endocrinol (Lausanne). 2024;15:1284144.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3248_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12933-025-03063-2","volume":"25","author":"W Zheng","year":"2026","unstructured":"Zheng W, Man Z, Li Y, et al. Association between the triglyceride glucose index: Chinese visceral adiposity index (TyG-CVAI) and new-onset cardiovascular disease in middle-aged and older adults-insights from the China Health and Retirement Longitudinal Study (CHARLS). Cardiovasc Diabetol. 2026;25(1):48.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3248_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12933-025-02960-w","volume":"24","author":"L Zhang","year":"2025","unstructured":"Zhang L, Li S, Liu D, et al. The relationship between C-reactive protein-triglyceride-glucose index and cardiovascular disease: insights from the China Health and Retirement Longitudinal Study (CHARLS). Cardiovasc Diabetol. 2025;24(1):410.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3248_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Hu Y, Smith JP, et al. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2012;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"3248_CR21","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D'Agostino","year":"2008","unstructured":"D\u2019Agostino RB, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743\u201353.","journal-title":"Circulation"},{"key":"3248_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.905266","volume":"13","author":"G-T Ruan","year":"2022","unstructured":"Ruan G-T, Xie H-L, Zhang H-Y, et al. A novel inflammation and insulin resistance related indicator to predict the survival of patients with cancer. Front Endocrinol (Lausanne). 2022;13:905266.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3248_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.959860","volume":"13","author":"L Pan","year":"2022","unstructured":"Pan L, Xu Q, Liu J, et al. Dose\u2013response relationship between Chinese visceral adiposity index and type 2 diabetes mellitus among middle-aged and elderly Chinese. Front Endocrinol (Lausanne). 2022;13:959860.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3248_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12933-025-02593-z","volume":"24","author":"Y Hu","year":"2025","unstructured":"Hu Y, Liang Y, Li J, et al. Correlation between atherogenic index of plasma and cardiovascular disease risk across cardiovascular\u2013kidney\u2013metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):40.","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"3248_CR25","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/eurheartj\/ehad885","volume":"45","author":"D He","year":"2024","unstructured":"He D, Wang Z, Li J, et al. Changes in frailty and incident cardiovascular disease in three prospective cohorts. Eur Heart J. 2024;45(12):1058\u201368.","journal-title":"Eur Heart J"},{"key":"3248_CR26","doi-asserted-by":"publisher","DOI":"10.2196\/75887","volume":"8","author":"Z Zeng","year":"2025","unstructured":"Zeng Z, Hsu CL, Sit CH-P, et al. The role of physical activity and physical function in predicting physical frailty transitions in Chinese older adults: longitudinal observational study from CHARLS. JMIR Aging. 2025;8:e75887.","journal-title":"JMIR Aging"},{"issue":"5","key":"3248_CR27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/EDE.0b013e318225c2be","volume":"22","author":"J Textor","year":"2011","unstructured":"Textor J, Hardt J, Kn\u00fcppel S. DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology. 2011;22(5):745.","journal-title":"Epidemiology"},{"key":"3248_CR28","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2288-8-70","volume":"8","author":"I Shrier","year":"2008","unstructured":"Shrier I, Platt RW. Reducing bias through directed acyclic graphs. BMC Med Res Methodol. 2008;8:70.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"3248_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-025-02642-7","volume":"24","author":"P Zhang","year":"2025","unstructured":"Zhang P, Mo D, Zeng W, et al. Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular\u2013kidney\u2013metabolic syndrome stage 0\u20133: a cohort study. Cardiovasc Diabetol. 2025;24(1):92.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"3248_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2025.104101","volume":"35","author":"M Lin","year":"2025","unstructured":"Lin M, Zhou Y, Han S, et al. Visceral fat and its dynamic changes are associated with incident stroke: evidence from the China Health and Retirement Longitudinal Study. Nutr Metab Cardiovasc Dis. 2025;35(9):104101.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"3248_CR31","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"L-C Tao","year":"2022","unstructured":"Tao L-C, Xu J-N, Wang T-T, et al. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"3248_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.70109","volume":"41","author":"X Li","year":"2025","unstructured":"Li X, Maimaiti A, Ling Y, et al. Chinese Visceral Adiposity Index outperforms traditional anthropometric indices in predicting cardiovascular disease risk: a prospective cohort study. Diabetes Metab Res Rev. 2025;41(8):e70109.","journal-title":"Diabetes Metab Res Rev"},{"issue":"6","key":"3248_CR33","doi-asserted-by":"publisher","first-page":"5126","DOI":"10.1016\/j.ijcard.2013.07.113","volume":"168","author":"W Koenig","year":"2013","unstructured":"Koenig W. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy. Int J Cardiol. 2013;168(6):5126\u201334.","journal-title":"Int J Cardiol"},{"issue":"26","key":"3248_CR34","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"J-C Tardif","year":"2019","unstructured":"Tardif J-C, Kouz S, Waters DD, et al. Efficacy and safety of low-dose colchicine after myocardial infarction. N Engl J Med. 2019;381(26):2497\u2013505.","journal-title":"N Engl J Med"},{"issue":"12","key":"3248_CR35","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119\u201331.","journal-title":"N Engl J Med"},{"key":"3248_CR36","doi-asserted-by":"publisher","first-page":"14913","DOI":"10.2147\/JIR.S539644","volume":"18","author":"M Lin","year":"2025","unstructured":"Lin M, Zhou Y, Wu R, et al. Temporal relationship between visceral fat and inflammation, and their joint effect on cardiometabolic diseases: evidence from the China Health and Retirement Longitudinal Study (CHARLS). J Inflamm Res. 2025;18:14913\u201326.","journal-title":"J Inflamm Res"},{"key":"3248_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1562135","volume":"16","author":"Q Mao","year":"2025","unstructured":"Mao Q, Liu N, Xiong T, et al. Comparison of triglyceride-glucose index and triglyceride-glucose related indexes in predicting cardiovascular disease incidence among populations with cardiovascular\u2013kidney\u2013metabolic syndrome stages 0\u20133: a nationwide prospective cohort study. Front Endocrinol (Lausanne). 2025;16:1562135.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3248_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03084-5","author":"S-S Han","year":"2026","unstructured":"Han S-S, Liu Q, Zeng Z-M, et al. Association of various insulin resistance surrogate indices with aging acceleration and future risk of cardiovascular disease in individuals with cardiovascular\u2013kidney\u2013metabolic syndrome stages 0\u20133: insights from CHARLS 2011-2020 data. Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03084-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3248_CR39","doi-asserted-by":"publisher","first-page":"300060523116454","DOI":"10.1177\/03000605231164548","volume":"51","author":"CE Kosmas","year":"2023","unstructured":"Kosmas CE, Bousvarou MD, Kostara CE, et al. Insulin resistance and cardiovascular disease. J Int Med Res. 2023;51(3):3000605231164548.","journal-title":"J Int Med Res"},{"key":"3248_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102402","volume":"99","author":"Z Weijie","year":"2024","unstructured":"Weijie Z, Meng Z, Chunxiao W, et al. Obesity-induced chronic low-grade inflammation in adipose tissue: a pathway to Alzheimer\u2019s disease. Ageing Res Rev. 2024;99:102402.","journal-title":"Ageing Res Rev"},{"issue":"2","key":"3248_CR41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1161\/CIRCRESAHA.121.319582","volume":"131","author":"K Park","year":"2022","unstructured":"Park K, Li Q, Lynes MD, et al. Endothelial cells induced progenitors into brown fat to reduce atherosclerosis. Circ Res. 2022;131(2):168\u201383.","journal-title":"Circ Res"},{"issue":"2","key":"3248_CR42","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000208098","volume":"102","author":"S Chaturvedi","year":"2023","unstructured":"Chaturvedi S, De Marchis GM. Inflammatory biomarkers and stroke subtype: an important new frontier. Neurology. 2023;102(2):e208098.","journal-title":"Neurology"},{"issue":"10","key":"3248_CR43","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1001\/jamacardio.2020.2413","volume":"5","author":"R Puri","year":"2020","unstructured":"Puri R, Nissen SE, Arsenault BJ, et al. Effect of C-Reactive Protein on Lipoprotein(a)-Associated cardiovascular risk in optimally treated patients with high-risk vascular disease: a prespecified secondary analysis of the ACCELERATE Trial. JAMA Cardiol. 2020;5(10):1136\u201343.","journal-title":"JAMA Cardiol"},{"key":"3248_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11154358","author":"GP P\u00fcschel","year":"2022","unstructured":"P\u00fcschel GP, Klauder J, Henkel J. Macrophages, low-grade inflammation, insulin resistance and hyperinsulinemia: a mutual ambiguous relationship in the development of metabolic diseases. J Clin Med. 2022. https:\/\/doi.org\/10.3390\/jcm11154358.","journal-title":"J Clin Med"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03248-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03248-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03248-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:35:56Z","timestamp":1787020556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03248-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3248"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03248-3","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is conducted in accordance with the Declaration of Helsinki. Approval for the CHARLS was granted by the Ethics Committee at Peking University (IRB00001052-11015); each participant included in this study signed a written informed consent form before taking the survey.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"237"}}